To test whether defects in cholesterol efflux observed with genetic Jak2 deficiency may also be affected by pharmacologic inhibition, we examined the effects of the JAK2 inhibitor AG490. Here, JAK2 is linked to hyperinsulinemic hypoglycemia, familial, 4.